These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 28780725

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
    Chow R, Valdez C, Chow N, Zhang D, Im J, Sodhi E, Lock M.
    Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy.
    Serafimovska T, Darkovska-Serafimovska M, Stefkov G, Arsova-Sarafinovska Z, Balkanov T.
    Folia Med (Plovdiv); 2020 Dec 31; 62(4):668-678. PubMed ID: 33415919
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Pergolizzi JV, Taylor R, LeQuang JA, Zampogna G, Raffa RB.
    Cancer Chemother Pharmacol; 2017 Mar 31; 79(3):467-477. PubMed ID: 28235999
    [Abstract] [Full Text] [Related]

  • 8. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
    Alderman B, Hui D, Mukhopadhyay S, Bouleuc C, Case AA, Amano K, Crawford GB, de Feo G, Sbrana A, Tanco K, To J, Garsed J, Davis M.
    Support Care Cancer; 2022 Dec 16; 31(1):39. PubMed ID: 36525085
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.
    Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ.
    BMJ; 2001 Jul 07; 323(7303):16-21. PubMed ID: 11440936
    [Abstract] [Full Text] [Related]

  • 11. Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics.
    May MB, Glode AE.
    Cancer Manag Res; 2016 Jul 07; 8():49-55. PubMed ID: 27274310
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of cannabinoids.
    McGilveray IJ.
    Pain Res Manag; 2005 Jul 07; 10 Suppl A():15A-22A. PubMed ID: 16237477
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
    Parker LA, Kwiatkowska M, Burton P, Mechoulam R.
    Psychopharmacology (Berl); 2004 Jan 07; 171(2):156-61. PubMed ID: 13680081
    [Abstract] [Full Text] [Related]

  • 19. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N, Wells C, Häuser W.
    Eur J Pain; 2018 Mar 07; 22(3):440-454. PubMed ID: 29134767
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.